Results 31 to 40 of about 278,227 (245)
Inactive Graves’ orbitopathy: to treat or not to treat?
Российский офтальмологический журнал, 2023 Purpose: to evaluate the expediency and efficacy of conservative therapy of patients with inactive stages of Graves’ orbitopathy complicated by optical neuropathy. Materials and methods.
O. G. Panteleeva, F. H. Batyrbekova
doaj +1 more source
Antagonistic Autoantibodies to Insulin-Like Growth Factor-1 Receptor Associate with Poor Physical Strength [PDF]
, 2020 Natural autoantibodies to the IGF1 receptor (IGF1R-aAb) have been described in relation to Graves' ophthalmopathy. Other physiological roles of natural IGF1R-aAb are not known. We hypothesized that IGF1R-aAb may be related to muscle development.
Becker, Niels-Peter +7 more
core +1 more source
Significance of HLA in the development of Graves’ orbitopathy
Genes and Immunity, 2023 Graves’ disease (GD), similarly to most autoimmune disease, is triggered by environmental factors in genetically predisposed individuals. Particular HLA alleles increase or decrease GD risk.
M. Stasiak +4 more
semanticscholar +1 more source
Frontiers in Endocrinology, 2023 Design Retrospective study Purpose The purpose of this retrospective study was to assess the changes in thyroid-stimulating hormone receptor (TSH-R) antibody levels following treatment in patients with moderate-to-severe and active Graves’ orbitopathy ...
Jungyul Park +3 more
semanticscholar +1 more source
A rare case of severe bilateral Graves’ orbitopathy involving an anophthalmic socket
Endocrinology, Diabetes & Metabolism Case Reports, 2023 This is a report of a rare case of Graves’ hyperthyroidism associated with severe bilateral Graves’ orbitopathy, in a patient with an anophthalmic eye socket.
Mudassir Ali +6 more
doaj +1 more source
Diagnostic accuracy of short-time inversion recovery sequence in Graves' ophthalmopathy before and after prednisone treatment [PDF]
, 2014 Introduction: In Graves' Ophthalmopathy, it is important to distinguish active inflammatory phase, responsive to immunosuppressive treatment, from fibrotic unresponsive inactive one.
Belfiore, M. P. +8 more
core +1 more source
Eye, 2023 To assess sex-specific risk factors for Graves’ orbitopathy (GO) in newly diagnosed Graves’ disease (GD) patients. A retrospective cohort study was conducted using the National Health Insurance Service’s sample database, which consisted of 1,137,861 ...
Jooyoung Lee +3 more
semanticscholar +1 more source
Computed tomography for diagnosing Graves ophtalmopathy [PDF]
Romanian Medical Journal, 2021 Graves ophtalmopathy (GO), thyroid eye disease (TED) and thyroid - associated orbitopathy (TAO) are terms referring to an autoimmune inflammatory process that affects the adipogenesis of orbital fat and periorbital tissue, associated with dysthyroidism ...
Mihai Leonard C. Grecescu
doaj +1 more source
Cell density dependent stimulation of PAI-1 and hyaluronan synthesis by TGF-[béta] in orbital fibroblasts [PDF]
, 2018 L
Berta, Eszter +10 more
core +1 more source
Changes in the gut microbiota of patients with Graves' orbitopathy according to severity grade
Clinical and Experimental Ophthalmology, 2023 To explore the changes of gut microbiota in Graves' orbitopathy (GO) patients of different severity grades and to identify the pathogenic bacteria of GO and the associated mechanism.
Qianshi Zhang +7 more
semanticscholar +1 more source